我们于1987年5月～1988年3月,试用肌苷静脉滴注加小剂量安体舒通治疗肝硬变顽固性腹水24例。病例选择与分组:选择住院治疗的肝硬变腹水患者48例,其中肝炎后肝硬变43例,酒精性肝硬变2例,原因不明者3例。本组伴上消化道出血10例,自发性腹膜炎24例,肝肾综合征B例,肝昏迷5例。根据Child分类标准,所有病例均属C级。将上述患者随机分成两组:治疗组24例,其中男18例,女6例,年龄19～64岁;对照组24例,其中男19例,女5例,年龄21～66岁。两组病情相似。治疗方法 We in May 1987 ~ March 1988, trial inosine intravenous infusion of small doses of spironolactone treatment of liver cirrhosis with ascites in 24 cases. Case Selection and Grouping: Forty-eight patients with cirrhosis and ascites were enrolled in this study. Among them, 43 were posthepatitic cirrhosis, 2 were alcoholic cirrhosis, and 3 were unexplained. The group with upper gastrointestinal bleeding in 10 cases, 24 cases of spontaneous peritonitis, hepatorenal syndrome B cases, hepatic coma in 5 cases. According to Child classification criteria, all cases are C-level. The patients were randomly divided into two groups: treatment group of 24 patients, including 18 males and 6 females, aged 19 to 64 years; control group of 24 patients, 19 males and 5 females, aged 21 to 66 years. The two groups were similar. treatment method